Steven Leonard Chapman - Jun 28, 2024 Form 4 Insider Report for Natera, Inc. (NTRA)

Signature
/s/ Tami Chen, Attorney-in-Fact
Stock symbol
NTRA
Transactions as of
Jun 28, 2024
Transactions value $
-$4,053,805
Form type
4
Date filed
7/2/2024, 09:05 PM
Previous filing
Jun 18, 2024
Next filing
Jul 23, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NTRA Common Stock Options Exercise +37.5K +17.58% 251K Jun 28, 2024 Direct F1
transaction NTRA Common Stock Sale -$2.59M -24K -9.57% $107.73 227K Jul 1, 2024 Direct F2, F3
transaction NTRA Common Stock Sale -$1.2M -11.1K -4.88% $108.61 216K Jul 1, 2024 Direct F2, F4
transaction NTRA Common Stock Sale -$266K -2.43K -1.13% $109.43 213K Jul 1, 2024 Direct F2, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NTRA Restricted Stock Unit Options Exercise $0 -37.5K -50% $0.00 37.5K Jun 28, 2024 Common Stock 37.5K Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of the Issuer's Common Stock.
F2 The sale of shares was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 11, 2023.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $107.21 to $108.17 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $108.25 to $109.23 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.27 to $109.66 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6 On January 22, 2021, the Reporting Person was granted RSUs covering 75,000 shares of Common Stock which vest in tranches upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price. On June 28, 2024, the criteria was satisfied for the vesting of RSUs covering 37,500 shares of Common Stock.